Document is current
Any future updates will be listed below
-
Authors
Ammann, Markus
Gudmundsdottir, Hallbera
Habermann, Elizabeth B.
Santol, Jonas
Podrascanin, Vanja
Dong, Yawen
Thiels, Cornelius A.
Warner, Susanne G.
Truty, Mark J.
Kendrick, Michael L.
Smoot, Rory L.
Connolly, Heidi M.
Halfdanarson, Thorvardur R.
Cleary, Sean P.
Nagorney, David M.
Starlinger, Patrick P.
- License Information
-
More Information
Article History
First Online: 3 November 2025
Disclosure
: Thorvardur R. Halfdanarson: served on the consulting/advisory board for Ipsen, TerSera, ScioScientifc, Curium, Advanced Accelerator Applications (a Novartis company), Terumo, ITM Isotopen Technologien Muenchen, Perspective Therapeutics, Abdera Therapeutics, Exelixis, Camurus and Crinetics. Dr. Halfdanardson received research support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Camurus, Crinetics, ITM Isotopen Technologien Muenchen, and Perspective Therapeutics. All other authors have no conflicts of interest to declare.
